Medithera SA
5.4 FTEThe score of Medithera shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -16 % Total assets +61 % Headcount (avg FTE) -17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Medithera's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 11,471 € | ||||
| Equity | 399,044 € | ||||
| Cash | 28,460 € | ||||
| EBITDA | 66,049 € | ||||
| Total assets | 972,011 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 10 Oct 2025
- Year ended 31 Dec 2023filed on 29 Nov 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Medithera's financial analysis
- Solvency41.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Medithera
Medithera's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0429.134.433
- VAT number
- BE0429134433
- Peppol
- Registered · 0208:0429134433 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Jun 1986
- Registered office
- 1330 Rixensart
- Size
- Micro · 5.4 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Medithera (SA) has been based in Rixensart since 1986, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 11,471 € and equity of 399,044 €; its revenue is not published. With 5.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 41.1%, below the median of its sector (41.5%).
Companies similar to Medithera
Companies in the same business, of comparable size and area, outside its group.
- Apotheek THYS Retail sale of pharmaceutical products Houthalen-Helchteren · balance sheet 971,728 €
- Sybephar Retail sale of pharmaceutical products Oudenaarde · balance sheet 970,416 €
- Pharmacie DE LA Cour Retail sale of pharmaceutical products Brussels · balance sheet 975,061 €
- Pharmaplus Invest Retail sale of pharmaceutical products Forest · balance sheet 976,007 €
- Pharmasambre Retail sale of pharmaceutical products Sambreville · balance sheet 977,337 €
- Apoteek Ackerman A. Retail sale of pharmaceutical products Ghent · balance sheet 981,775 €
- Mentover Retail sale of pharmaceutical products Antwerp · balance sheet 981,994 €
- DE Pourcq Farma Retail sale of pharmaceutical products Mechelen · balance sheet 987,151 €
Frequently asked questions about Medithera
What is the revenue of Medithera?
Medithera files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Medithera?
In Belgium, the VAT number is the company number prefixed with BE: BE0429134433 for Medithera, if the company is VAT-registered. Its company number (CBE) is 0429.134.433.
Where is the registered office of Medithera?
According to the CBE register, the registered office of Medithera is in 1330 Rixensart.
What is the equity of Medithera?
At the close of the 2025 financial year, the equity of Medithera amounts to 399,044 €, a solvency of 41.1% of total assets.
How many people work at Medithera?
5.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Medithera?
The register lists 3 active mandates at Medithera. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Medithera
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →